Cargando…

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics

INTRODUCTION: Major depressive disorder (MDD) is a highly prevalent mental disorder affecting millions of people worldwide. However, a clear causative etiology of MDD remains unknown. In this study, we aimed to identify critical protein alterations in plasma from patients with MDD and integrate our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gui, Si-Wen, Liu, Yi-Yun, Zhong, Xiao-Gang, Liu, Xinyu, Zheng, Peng, Pu, Jun-Cai, Zhou, Jian, Chen, Jian-Jun, Zhao, Li-Bo, Liu, Lan-Xiang, Xu, Guowang, Xie, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995410/ https://www.ncbi.nlm.nih.gov/pubmed/29922061 http://dx.doi.org/10.2147/NDT.S164134

Ejemplares similares

Integrated Metabolomics and Proteomics Analysis Revealed Second Messenger System Disturbance in Hippocampus of Chronic Social Defeat Stress Rat
por: Yang, Li-Ning, et al.
Publicado: (2019)

Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study
por: Pan, Jun-Xi, et al.
Publicado: (2018)

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents
por: Jiang, Yuanliang, et al.
Publicado: (2022)

Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson’s Disease
por: Hu, Ling, et al.
Publicado: (2020)

Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder
por: Wu, Zhonghao, et al.
Publicado: (2022)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen, Jian-jun, et al.
Publicado: (2018)

Plasma proteomic data in bipolar II disorders and major depressive disorders
por: Lee, Hyunju, et al.
Publicado: (2021)

Disturbed phospholipid homeostasis in endoplasmic reticulum initiates tri-o-cresyl phosphate-induced delayed neurotoxicity
por: Zhu, Li, et al.
Publicado: (2016)

Chronic Stress Disturbs Metabolome of Blood Plasma and Urine in Diabetic Rats
por: Ren, Yu, et al.
Publicado: (2018)

Clinical symptoms, thyroid dysfunction, and metabolic disturbances in first-episode drug-naïve major depressive disorder patients with suicide attempts: A network perspective
por: Peng, Pu, et al.
Publicado: (2023)

Recent Progress in Mass Spectrometry-Based Metabolomics in Major Depressive Disorder Research
por: Liu, Mingxia, et al.
Publicado: (2023)

Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients
por: Wei, HongYan, et al.
Publicado: (2021)

Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder
por: Martins-de-Souza, Daniel
Publicado: (2014)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
por: Liu, Lan-Ying, et al.
Publicado: (2018)

Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry
por: Liu, Shuxin, et al.
Publicado: (2017)

Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: Undirected and Bayesian network analyses
por: Peng, Pu, et al.
Publicado: (2023)

Metabolomic changes in animal models of depression: a systematic analysis
por: Pu, Juncai, et al.
Publicado: (2021)

Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders
por: Cui, Feihuan, et al.
Publicado: (2021)

Chronic Stress in a Rat Model of Depression Disturbs the Glutamine–Glutamate–GABA Cycle in the Striatum, Hippocampus, and Cerebellum
por: Xu, Shaohua, et al.
Publicado: (2020)

Effects of pharmacological treatment on metabolomic alterations in animal models of depression
por: Pu, Juncai, et al.
Publicado: (2022)

The Functional Anatomy of Psychomotor Disturbances in Major Depressive Disorder
por: Liberg, Benny, et al.
Publicado: (2015)

Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls
por: Homorogan, C., et al.
Publicado: (2022)

Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics
por: Yuan, Xiaomin, et al.
Publicado: (2021)

Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension
por: Wawrzyniak, Renata, et al.
Publicado: (2023)

Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study
por: Naifar, M., et al.
Publicado: (2023)

Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study
por: Naifar, M., et al.
Publicado: (2023)

Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats
por: Liu, Yi-Yun, et al.
Publicado: (2017)

Association between Erythrocyte Membrane Phospholipid Fatty Acids and Sleep Disturbance in Chinese Children and Adolescents
por: Tang, Jun, et al.
Publicado: (2018)

Comparative proteomic analysis of plasma from bipolar depression and depressive disorder: identification of proteins associated with immune regulatory
por: Chen, Jin, et al.
Publicado: (2015)

Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
por: Huan, Yuhang, et al.
Publicado: (2021)

Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
por: An, Rui, et al.
Publicado: (2022)

The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023)

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
por: Liu, Duan, et al.
Publicado: (2018)

Plasma Metabolomic and Lipidomic Profiling of Metabolic Dysfunction-Associated Fatty Liver Disease in Humans Using an Untargeted Multiplatform Approach
por: Lin, Xiangping, et al.
Publicado: (2022)

Correction: Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression
por: Liu, Yiyun, et al.
Publicado: (2021)

Analysis of metabolic disturbances attributable to sepsis-induced myocardial dysfunction using metabolomics and transcriptomics techniques
por: Jia, Xiaonan, et al.
Publicado: (2022)

Risk Factors for Anxiety in Major Depressive Disorder Patients
por: Xin, Li-Min, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jgcaikec9a6mn7psmjm1n16s33